SuplicaƱa, R-jay B.
HRN: 28-04-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2025
CEFTRIAXONE 1G (VIAL)
11/02/2025
11/08/2025
IV
2g
OD
TBI
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes